Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gilbertson

Showing results (141-150 of 236) with videos related to

Pageof 24
Sort By:
Journal of Neuro-Oncology|November 1, 2015
Preclinical studies of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in pediatric brain tumorsMarie Morfouace, Birgit Nimmervoll, Nidal Boulos, et al.
Journal of Chromatography. B, Biomedical Applications|November 17, 1995
Determination of ceftiofur and its desfuroylceftiofur-related metabolites in swine tissues by high-performance liquid chromatographyM G Beconi-Barker, R D Roof, L Millerioux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2004
Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastomaAmar Gajjar, Roberto Hernan, Mehmet Kocak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase I study of everolimus in pediatric patients with refractory solid tumorsMaryam Fouladi, Fred Laningham, Jianrong Wu, et al.
Genes & Development|July 7, 2022
Primary cilia control translation and the cell cycle in medulloblastomaYong Ha Youn, Shirui Hou, Chang-Chih Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
TP53 mutations in favorable-risk Wnt/Wingless-subtype medulloblastomasJanet C Lindsey, Rebecca M Hill, Hisham Megahed, et al.
Pediatric Blood & Cancer|April 5, 2013
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium studyTrent R Hummel, Lars Wagner, Charlotte Ahern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium studySridharan Gururangan, Susan N Chi, Tina Young Poussaint, et al.
Nature Reviews. Cancer|November 24, 2012
Medulloblastomics: the end of the beginningPaul A Northcott, David T W Jones, Marcel Kool, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapyTanya M Tekautz, Christine E Fuller, Susan Blaney, et al.
Pageof 24

Showing results (141-150 of 236) with videos related to

Sort By:
Pageof 24
Journal of Neuro-Oncology|November 1, 2015
Preclinical studies of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in pediatric brain tumorsMarie Morfouace, Birgit Nimmervoll, Nidal Boulos, et al.
Journal of Chromatography. B, Biomedical Applications|November 17, 1995
Determination of ceftiofur and its desfuroylceftiofur-related metabolites in swine tissues by high-performance liquid chromatographyM G Beconi-Barker, R D Roof, L Millerioux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2004
Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastomaAmar Gajjar, Roberto Hernan, Mehmet Kocak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase I study of everolimus in pediatric patients with refractory solid tumorsMaryam Fouladi, Fred Laningham, Jianrong Wu, et al.
Genes & Development|July 7, 2022
Primary cilia control translation and the cell cycle in medulloblastomaYong Ha Youn, Shirui Hou, Chang-Chih Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
TP53 mutations in favorable-risk Wnt/Wingless-subtype medulloblastomasJanet C Lindsey, Rebecca M Hill, Hisham Megahed, et al.
Pediatric Blood & Cancer|April 5, 2013
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium studyTrent R Hummel, Lars Wagner, Charlotte Ahern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium studySridharan Gururangan, Susan N Chi, Tina Young Poussaint, et al.
Nature Reviews. Cancer|November 24, 2012
Medulloblastomics: the end of the beginningPaul A Northcott, David T W Jones, Marcel Kool, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapyTanya M Tekautz, Christine E Fuller, Susan Blaney, et al.
Pageof 24